QIKOVRIX Trademark

Trademark Overview


On Thursday, March 17, 2022, a trademark application was filed for QIKOVRIX with the United States Patent and Trademark Office. The USPTO has given the QIKOVRIX trademark a serial number of 97316764. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Thursday, June 1, 2023. This trademark is owned by GlaxoSmithKline Biologicals SA. The QIKOVRIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
qikovrix

General Information


Serial Number97316764
Word MarkQIKOVRIX
Filing DateThursday, March 17, 2022
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateThursday, June 1, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 31, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, June 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Thursday, June 1, 2023ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Thursday, June 1, 2023ABANDONMENT - AFTER INTER PARTES DECISION
Thursday, June 1, 2023OPPOSITION TERMINATED NO. 999999
Thursday, June 1, 2023OPPOSITION SUSTAINED NO. 999999
Thursday, March 2, 2023OPPOSITION INSTITUTED NO. 999999
Thursday, March 2, 2023OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, January 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 31, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 27, 2022ASSIGNED TO EXAMINER
Wednesday, August 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 21, 2022NEW APPLICATION ENTERED